This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Tibolone: additional cost negligible in postmenopausal women. Pharmacoecon. Outcomes News 295, 9 (2001). https://doi.org/10.1007/BF03269060
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269060